Blogs
Healthcare and Medtech Research Reports
Jun 22, 2020
The Geographic atrophy market size is anticipated to increase during the study period 2017–2030 owing to increasing GA prevalence, better understanding of disease pathophysiology, better therapies and pipeline candidates aimed at addressing the disease from its root. Geographic Atrophy (GA) is an advanced form ...
Read More...
Oct 30, 2019
Geographic atrophy (GA) is a severe, progressive, irreversible vision loss in old age people. The loss in the vision is due to the damage in a small portion of the retina at the back of the eye, known as the macula. Since the loss of vision is due to age, it is also referred to as Age-related macular degeneration. ...
Read More...
Intratumoral Cancer Therapy: A Potential Weapon To Fight the Battle Against Cancer
Aug 05, 2026
The Next Wave of Radioligand Therapies: 5 Candidates to Watch
Mar 20, 2026
Newsletter/Whitepaper